SEC Form 3 · accession 0001209191-19-005144
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Peters
Officer — VP of Finance
Period of report
Jan 18, 2019
Accepted (ET)
Jan 24, 2019 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 861 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.82 | holding | — | — | — | — | Jan 30, 2028 | Common Stock | 60,000 | — | D |
Explanation of responses
- F1This option was granted on January 31, 2018. The shares underlying this option vested as to 25% of the shares on January 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.